These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2393291)

  • 1. Penetration of SCH-39304, a new antifungal triazole, into cerebrospinal fluid of primates.
    Walsh TJ; Lester-McCully C; Rinaldi MG; Wallace JE; Balis FM; Lee JW; Pizzo PA; Poplack DG
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1281-4. PubMed ID: 2393291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tissue penetration of Sch 39304 in granulocytopenic and nongranulocytopenic rabbits.
    Lee JW; Lin C; Loebenberg D; Rubin M; Pizzo PA; Walsh TJ
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1932-5. PubMed ID: 2610504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys.
    Nomeir AA; Kumari P; Hilbert MJ; Gupta S; Loebenberg D; Cacciapuoti A; Hare R; Miller GH; Lin CC; Cayen MN
    Antimicrob Agents Chemother; 2000 Mar; 44(3):727-31. PubMed ID: 10681346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of SCH-39304 in human immunodeficiency virus-infected patients following chronic oral dosing.
    Hardin TC; Sharkey PK; Lam YF; Wallace JE; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2790-3. PubMed ID: 1482146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic evaluation of fluconazole in healthy volunteers].
    Shiba K; Saito A; Miyahara T
    Jpn J Antibiot; 1989 Jan; 42(1):17-30. PubMed ID: 2540363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posaconazole (Noxafil, SCH 56592), a new azole antifungal drug, was a discovery based on the isolation and mass spectral characterization of a circulating metabolite of an earlier lead (SCH 51048).
    Nomeir AA; Pramanik BN; Heimark L; Bennett F; Veals J; Bartner P; Hilbert M; Saksena A; McNamara P; Girijavallabhan V; Ganguly AK; Lovey R; Pike R; Wang H; Liu YT; Kumari P; Korfmacher W; Lin CC; Cacciapuoti A; Loebenberg D; Hare R; Miller G; Pickett C
    J Mass Spectrom; 2008 Apr; 43(4):509-17. PubMed ID: 18059003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma pharmacokinetics and tissue penetration of a novel antifungal triazole, Bay R 3783, and its long-lasting active metabolite, Bay U 3625, in rabbits.
    Lee JW; Ritter W; Lecciones J; Kelly P; Pizzo PA; Walsh TJ
    J Antimicrob Chemother; 1991 Jun; 27(6):837-44. PubMed ID: 1938690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
    Clemons KV; Homola ME; Stevens DA
    Antimicrob Agents Chemother; 1995 May; 39(5):1169-72. PubMed ID: 7625808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.
    Connolly P; Wheat J; Schnizlein-Bick C; Durkin M; Kohler S; Smedema M; Goldberg J; Brizendine E; Loebenberg D
    Antimicrob Agents Chemother; 1999 Feb; 43(2):322-8. PubMed ID: 9925526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of genaconazole, a potent antifungal drug, in men.
    Lin C; Kim H; Radwanski E; Affrime M; Brannan M; Cayen MN
    Antimicrob Agents Chemother; 1996 Jan; 40(1):92-6. PubMed ID: 8787886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies comparison of pharmacokinetics of the novel triazole antifungal agent SYN-2869 and its derivatives.
    Khan JK; Montaseri H; Poglod M; Bu HZ; Zuo Z; Salama SM; Daneshtalab M; Micetich RG
    Antimicrob Agents Chemother; 2000 Apr; 44(4):910-5. PubMed ID: 10722490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of antacid and cimetidine on the oral absorption of the antifungal agent SCH 39304.
    Kosoglou T; Perentesis GP; Affrime MB; Lin CC; Mojaverian P; Radwanski E; Vlasses PH
    J Clin Pharmacol; 1990 Jul; 30(7):638-42. PubMed ID: 2391395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of SCH 39304 by megabore capillary gas-liquid chromatography.
    Wallace JE; Mojaverian P; Lin CC; Kim HK; Harris SC; Chen TJ; Rinaldi MG
    J Anal Toxicol; 1994; 18(2):118-21. PubMed ID: 8207932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isavuconazole for treatment of refractory coccidioidal meningitis with concomitant cerebrospinal fluid and plasma therapeutic drug monitoring.
    Davis MR; Chang S; Gaynor P; McCreary EK; Allyn P
    Med Mycol; 2021 Sep; 59(9):939-942. PubMed ID: 34143187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients.
    Lutsar I; Roffey S; Troke P
    Clin Infect Dis; 2003 Sep; 37(5):728-32. PubMed ID: 12942409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis.
    Tucker RM; Williams PL; Arathoon EG; Levine BE; Hartstein AI; Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1988 Mar; 32(3):369-73. PubMed ID: 2835002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the oral triazole antimycotic vibunazole in animals.
    Ritter W; Plempel M
    J Antimicrob Chemother; 1984 Sep; 14(3):243-52. PubMed ID: 6490569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses.
    Colitz CM; Latimer FG; Cheng H; Chan KK; Reed SM; Pennick GJ
    Am J Vet Res; 2007 Oct; 68(10):1115-21. PubMed ID: 17916020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.
    Perfect JR; Durack DT
    J Antimicrob Chemother; 1985 Jul; 16(1):81-6. PubMed ID: 2995303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNS pharmacokinetics of antifungal agents.
    Kethireddy S; Andes D
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):573-81. PubMed ID: 17696807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.